treatmentoil

104 results found.

Top Stocks matching your search for "treatment oil"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

It reported positive outcomes in pleural mesotheli... See more

Mar, 20, 2023

* Best Available Therapy offers 6-8 months of Over... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
LCID

Lucid Group Inc

-29.21%

$11.57 - $8.19

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 18, 2023

CURING LEUKEMIA isn't a fly by night thing wit... See more

Jan, 18, 2023

CURING LEUKEMIA isn't a fly by night thing wit... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 5, 2023

I’m sure patient will rewards high.

Nov, 11, 2022

$HKD I wonder how long they will hold it I’m super... See more

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

It reported positive outcomes in pleural mesothelioma patients, including: Improved survival: Study patients lived around 11 months.

Mar, 20, 2023

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

Mar, 17, 2023

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

Mar, 17, 2023

* Best Available Therapy offers 6-8 months of Overall Survival * All pooled Regal patients, BAT and Gps combined, is 16 months.

Feb, 27, 2023

Now phase 3 trial is showing similar results to date where patients are living longer after Galinpepimut-S up to 1.5 year longer is a breakthrough for AML patients.

Feb, 25, 2023

- Best available treatment 6-8 months of os.

Feb, 24, 2023

- Best available treatment 6-8 months of os.

Feb, 1, 2023

- Cured GPS patients, continue to elongate the OS curve in Gps favor every day that goes by.

Feb, 1, 2023

$SLS In addition to GPs FDA approval for AML secondary Remission patients - Gps + Keytruda/Checkpoint Inhibition is also best in class for Ovarian cancer patients.

Feb, 1, 2023

$SLS NCT update, nice… They target 140 patients in 110 investigational sites.

LCID

Lucid Group Inc

-29.21%

$11.57 - $8.19

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 18, 2023

CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

Jan, 18, 2023

CURING LEUKEMIA isn't a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 5, 2023

I’m sure patient will rewards high.

Nov, 11, 2022

$HKD I wonder how long they will hold it I’m super patient I will be holding & adding more by days I’m not leaving 😂 soon or later it will eventually explode 🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀🚀